Palliative care as a component of high-value and cost-saving care during hospitalization for metastatic cancer

Article indépendant

LU, Sifan | RAKOVITCH, Eileen | HANNON, Breffni | ZIMMERMANN, Camilla | DHARMARAJAN, Kavita V. | YAN, Michael | DE ALMEIDA, John R. | YAO, Christopher M. K. L. | GILLESPIE, Erin F. | CHINO, Fumiko | YERRAMILLI, Divya | GOONARATNE, Ethan | ABDEL-RAHMAN, Fadwa | OTHMAN, Hiba | MHEID, Sara | TSAI, Chiaojung Jillian

PURPOSE: Randomized controlled trials have demonstrated that palliative care (PC) can improve quality of life and survival for outpatients with advanced cancer, but there are limited population-based data on the value of inpatient PC. We assessed PC as a component of high-value care among a nationally representative sample of inpatients with metastatic cancer and identified hospitalization characteristics significantly associated with high costs. METHODS: Hospitalizations of patients 18 years and older with a primary diagnosis of metastatic cancer from the National Inpatient Sample from 2010 to 2019 were analyzed. We used multivariable mixed-effects logistic regression to assess medical services, patient demographics, and hospital characteristics associated with higher charges billed to insurance and hospital costs. Generalized linear mixed-effects models were used to determine cost savings associated with provision of PC. RESULTS: Among 397,691 hospitalizations from 2010 to 2019, the median charge per admission increased by 24.9%, from $44,904 in US dollars (USD) to $56,098 USD, whereas the median hospital cost remained stable at $14,300 USD. Receipt of inpatient PC was associated with significantly lower charges (odds ratio [OR], 0.62 [95% CI, 0.61 to 0.64]; P < .001) and costs (OR, 0.59 [95% CI, 0.58 to 0.61]; P < .001). Factors associated with high charges were receipt of invasive medical ventilation (P < .001) or systemic therapy (P < .001), Hispanic patients (P < .001), young age (18-49 years, P < .001), and for-profit hospitals (P < .001). PC provision was associated with a $1,310 USD (-13.6%, P < .001) reduction in costs per hospitalization compared with no PC, independent of the receipt of invasive care and age. CONCLUSION: Inpatient PC is associated with reduced hospital costs for patients with metastatic cancer, irrespective of age and receipt of aggressive interventions. Integration of inpatient PC may de-escalate costs incurred through low-value inpatient interventions.

http://dx.doi.org/10.1200/OP.23.00576

Voir la revue «JCO oncology practice»

Autres numéros de la revue «JCO oncology practice»

Consulter en ligne

Suggestions

Du même auteur

Disparities in care management during termina...

Article indépendant | DEEB, Stephanie | JAMA network open | n°9 | vol.4

Importance: Many patients with metastatic cancer receive high-cost, low-value care near the end of life. Identifying patients with a high likelihood of receiving low-value care is an important step to improve appropriate end-of-li...

A worksheet to facilitate discussions of valu...

Article indépendant | MATHIS, Noah J. | JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | n°3 | vol.66

Context: Individual goals and values should drive medical decision making for patients with serious illness. Unfortunately, clinicians’ existing strategies to encourage reflection and communication regarding patients’ personal val...

Characterizing disparities in receipt of pall...

Article | KOHLI, Khushi | Supportive care in cancer | n°8 | vol.32

PURPOSE: Palliative care plays essential roles in cancer care. However, differences in receipt among individuals identifying as Asian American, Native Hawaiian, and Other Pacific Islanders (AA&NHPI) with cancer are not well-charac...

De la même série

Medical assistance in dying in patients with ...

Article indépendant | THABET, Chloe | JCO oncology practice | n°9 | vol.19

PURPOSE: Medical assistance in dying (MAiD) was legalized in Canada in 2016. To date, patients with cancer account for 69% of MAiD deaths, yet little information is available about these patients. We reviewed disease and treatment...

Anxiety and depression in metastatic cancer :...

Article indépendant | ARCH, Joanna J. | JCO oncology practice | n°12 | vol.19

PURPOSE: Providers treating adults with advanced cancer increasingly seek to engage patients and surrogates in advance care planning (ACP) and end-of-life (EOL) decision making; however, anxiety and depression may interfere with e...

End-of-life health resource utilization for l...

Article indépendant | LEUNG, Bonnie | JCO oncology practice | n°10 | vol.18

Purpose: Limited English-proficient (LEP) patients with non-small-cell lung cancer (NSCLC) may receive less palliative care services and more likely to receive aggressive end-of-life (EoL) care. Goals of this retrospective cohort ...

Palliative care use among people living with ...

Article indépendant | ISLAM, Jessica Y. | JCO oncology practice | n°10 | vol.18

Purpose: People living with HIV (PLWH) diagnosed with cancer are less likely to receive quality cancer treatment compared with HIV-negative patients. Timely provision of palliative care (PC) during cancer treatment can increase pa...

Patient, family, and clinician perspectives o...

Article indépendant | ODEJIDE, Oreofe O. | JCO oncology practice | n°10 | vol.18

Purpose: Adolescents and young adults (AYAs) with cancer have high rates of hospital deaths. It is not clear if this reflects their preferences or barriers to dying at home. Methods: Between December 2018 and January 2021, we cond...

Chargement des enrichissements...